Why the study?
Does aspirin dosage affect serum and urinary markers of thromboxane synthesis in patients with vascular disease?
Does aspirin dosage affect serum and urinary markers of thromboxane synthesis in patients with vascular disease?
Different aspirin dosages significantly affect serum and urinary markers of thromboxane synthesis, demonstrating a dose-dependent suppression of thromboxane in patients with vascular disease.
Answers are grounded in this paper and cite their sources.
Challenges low-dose aspirin preference for thromboxane suppression; confirms dose-dependent effects in vascular disease.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Hart et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: